| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |